These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9195405)

  • 1. Quantitative analysis of interferon alpha/beta receptor mRNA in the liver of patients with chronic hepatitis C: correlation with serum hepatitis C virus-RNA levels and response to treatment with interferon.
    Yatsuhashi H; Yamasaki K; Aritomi T; Maria P; Carmen D; Inoue O; Koga M; Yano M
    J Gastroenterol Hepatol; 1997 Jun; 12(6):460-7. PubMed ID: 9195405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of interferon alpha/beta receptor in the liver of chronic hepatitis C patients.
    Mizukoshi E; Kaneko S; Yanagi M; Ohno H; Kaji K; Terasaki S; Shimoda A; Matsushita E; Kobayashi K
    J Med Virol; 1998 Nov; 56(3):217-23. PubMed ID: 9783688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-alpha receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-alpha therapy of patients with chronic hepatitis C.
    Massirer KB; Hirata MH; Silva AE; Ferraz ML; Nguyen NY; Hirata RD
    Braz J Med Biol Res; 2004 May; 37(5):643-7. PubMed ID: 15107924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of interferon-alpha receptor mRNA in the liver in chronic liver diseases associated with hepatitis C virus: relation to effectiveness of interferon therapy.
    Fukuda R; Ishimura N; Ishihara S; Tokuda A; Satoh S; Sakai S; Akagi S; Watanabe M; Fukumoto S
    J Gastroenterol; 1996 Dec; 31(6):806-11. PubMed ID: 9027643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C.
    Yatsuhashi H; Fujino T; Matsumoto T; Inoue O; Koga M; Yano M
    J Hepatol; 1999 Jun; 30(6):995-1003. PubMed ID: 10406176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver.
    Fukuda R; Ishimura N; Hamamoto S; Moritani M; Uchida Y; Ishihara S; Akagi S; Watanabe M; Kinoshita Y
    J Med Virol; 2001 Mar; 63(3):220-7. PubMed ID: 11170061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy.
    Suzuki T; Tanaka E; Matsumoto A; Urushihara A; Sodeyama T
    J Med Virol; 1995 Jun; 46(2):162-8. PubMed ID: 7636506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver.
    Fukuda R; Ishimura N; Kushiyama Y; Moriyama N; Ishihara S; Nagasawa S; Miyake T; Niigaki M; Satoh S; Sakai S; Akagi S; Watanabe M; Fukumoto S
    J Hepatol; 1997 Mar; 26(3):455-61. PubMed ID: 9075649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C.
    Orito E; Mizokami M; Nakano T; Terashima H; Nojiri O; Sakakibara K; Mizuno M; Ogino M; Nakamura M; Matsumoto Y
    J Med Virol; 1994 Dec; 44(4):410-4. PubMed ID: 7897373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of soluble interferon Alfa/Beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C.
    Mizukoshi E; Kaneko S; Kaji K; Terasaki S; Matsushita E; Muraguchi M; Ohmoto Y; Kobayashi K
    Hepatology; 1999 Nov; 30(5):1325-31. PubMed ID: 10534358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferon receptor and response to interferon therapy in chronic hepatitis C patients: a prospective study.
    Fujiwara D; Hino K; Yamaguchi Y; Kubo Y; Yamashita S; Uchida K; Konishi T; Nakamura H; Korenaga M; Okuda M; Okita K
    J Viral Hepat; 2004 Mar; 11(2):136-40. PubMed ID: 14996348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of serum hepatitis C virus levels in patients with chronic hepatitis C treated with two courses of interferon administration.
    Saitoh Y; Miura M; Niitsuma H; Numata N; Ohori H; Ishii M; Toyota T
    Tohoku J Exp Med; 1994 Aug; 173(4):361-9. PubMed ID: 7529950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between the intrahepatic expression of interferon-alpha receptor mRNA and the histological progress of hepatitis C virus-associated chronic liver diseases.
    Ishimura N; Fukuda R; Fukumoto S
    J Gastroenterol Hepatol; 1996 Aug; 11(8):712-7. PubMed ID: 8872766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.
    Lau GK; Davis GL; Wu SP; Gish RG; Balart LA; Lau JY
    Hepatology; 1996 Jun; 23(6):1318-23. PubMed ID: 8675145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Earlier loss of hepatitis C virus RNA in interferon therapy can predict a long-term response in chronic hepatitis C.
    Kakumu S; Aiyama T; Okumura A; Iwata K; Ishikawa T; Yoshioka K
    J Gastroenterol Hepatol; 1997 Jun; 12(6):468-72. PubMed ID: 9195406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C.
    Lau JY; Mizokami M; Ohno T; Diamond DA; Kniffen J; Davis GL
    Lancet; 1993 Nov; 342(8881):1208-9. PubMed ID: 7901531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy.
    Shindo M; Arai K; Sokawa Y; Okuno T
    Ann Intern Med; 1995 Apr; 122(8):586-91. PubMed ID: 7887552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of interferon therapy in patients with chronic hepatitis C. Comparison between non-drinkers and drinkers.
    Okazaki T; Yoshihara H; Suzuki K; Yamada Y; Tsujimura T; Kawano K; Yamada Y; Abe H
    Scand J Gastroenterol; 1994 Nov; 29(11):1039-43. PubMed ID: 7871371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.
    Chemello L; Cavalletto L; Casarin C; Bonetti P; Bernardinello E; Pontisso P; Donada C; Belussi F; Martinelli S; Alberti A
    Ann Intern Med; 1996 Jun; 124(12):1058-60. PubMed ID: 8633819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment.
    Orito E; Mizokami M; Suzuki K; Ohba KI; Ohno T; Mizuno M; Iijima Y; Saito H; Nemoto A; Nukuta N
    J Gastroenterol Hepatol; 1997 Jan; 12(1):58-61. PubMed ID: 9076625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.